Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CSCI

COSCIENS Biopharma (CSCI) Stock Price, News & Analysis

COSCIENS Biopharma logo

About COSCIENS Biopharma Stock (NASDAQ:CSCI)

Key Stats

Today's Range
$2.50
$2.98
50-Day Range
$2.61
$3.95
52-Week Range
$1.96
$4.61
Volume
58,328 shs
Average Volume
20,392 shs
Market Capitalization
$8.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COSCIENS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSCI Stock News Headlines

1 Hour Once A Day
My top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to help regular investors generate enough income to become financially independent… Without taking on excessive amounts of risk. I’m talking about having the opportunity to collect $500 on Monday… $563 on Wednesday… Then as much as $625 on Friday.tc pixel
CSCI COSCIENS Biopharma Inc.
See More Headlines

CSCI Stock Analysis - Frequently Asked Questions

COSCIENS Biopharma Inc. (NASDAQ:CSCI) issued its earnings results on Thursday, August, 14th. The company reported ($0.85) EPS for the quarter. The firm earned $2.75 million during the quarter. COSCIENS Biopharma had a negative net margin of 199.55% and a negative trailing twelve-month return on equity of 149.49%.

Based on aggregate information from My MarketBeat watchlists, some other companies that COSCIENS Biopharma investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
8/14/2025
Today
10/08/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CSCI
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.31 million
Net Margins
-199.55%
Pretax Margin
-189.27%
Return on Equity
-149.49%
Return on Assets
-54.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.98
Quick Ratio
2.65

Sales & Book Value

Annual Sales
$9.44 million
Price / Sales
0.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.49 per share
Price / Book
0.75

Miscellaneous

Outstanding Shares
3,176,000
Free Float
3,173,000
Market Cap
$8.29 million
Optionable
N/A
Beta
0.91
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CSCI) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners